Clinical, biochemical and pathological features of low-renin (“primary”) hyperaldosteronism (Q67260210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:622981 AND SRC:MED&resulttype=core&format=json

11 September 2019

title

Clinical, biochemical and pathological features of low-renin ("primary") hyperaldosteronism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:622981 AND SRC:MED&resulttype=core&format=json

11 September 2019

Clinical, biochemical and pathological features of low-renin (“primary”) hyperaldosteronism (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Cardiology and cardiovascular medicine

13 August 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

13 August 2023

author name string

J. B. Ferriss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

D. G. Beevers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

J. J. Brown

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

D. L. Davies

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

R. Fraser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

A. F. Lever

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

P. Mason

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

A. M. Neville

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

J. I. Robertson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:622981

16 July 2022

language of work or name

English

0 references

publication date

1 March 1978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:622981 AND SRC:MED&resulttype=core&format=json

full work available at URL

11 September 2019

https://api.elsevier.com/content/article/PII:0002870378903708?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

https://api.elsevier.com/content/article/PII:0002870378903708?httpAccept=text/plain

13 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

13 August 2023

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:622981 AND SRC:MED&resulttype=core&format=json

11 September 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:622981 AND SRC:MED&resulttype=core&format=json

11 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:622981 AND SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

375-388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:622981 AND SRC:MED&resulttype=core&format=json

Primary aldosteronism versus hypertensive disease with secondary aldosteronism

11 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

13 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

NORMOKALEMIC PRIMARY ALDOSTERONISM. A DETECTABLE CAUSE OF CURABLE "ESSENTIAL" HYPERTENSION

13 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

PLASMA RENIN IN A CASE OF CONN'S SYNDROME WITH FIBRINOID LESIONS: USE OF SPINONOLACTONE IN TREATMENT.

13 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Plasma renin concentration in human hypertension . II. Renin in relation to aetiology

13 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Plasma-renin and aldosterone secretion in hypertensive patients with renal or renal artery lesions.

13 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

THE RENIN CONTENT OF THE BLOOD OF HUMANS AND DOGS UNDER SEVERAL CONDITIONS

13 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity

13 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Primary Aldosteronism with Suppressed Plasma Renin Activity Due to Bilateral Nodular Adrenocortical Hyperplasia

13 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Secondary aldosteronism and reduced plasma renin in hypertensive disease

13 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Childhood primary aldosteronism with bilateral adrenocortical hyperplasia: Plasma renin activity as an aid to diagnosis

13 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Primary aldosteronism: experience with current diagnostic criteria and surgical treatment in fourteen patients

13 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Hypertension and aldosteronism in solitary adenomas and nodular hyperplasia of the adrenal cortex

13 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour

13 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The syndrome of primary aldosteronism

13 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The intercurrent hypertension of primary aldosteronism

13 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Primary aldosteronism. A study in contrasts

13 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone

13 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

A new form of congenital adrenal hyperplasia

13 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

A case of glucocorticoid-responsive hyperaldosteronism

13 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

A kindred with familial glucocorticoid suppressible aldosteronism.

13 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Adrenal cortical carcinoma producing solely mineralocorticoid effect

13 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Potassium deficiency of renal and adrenal origin

13 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Physiologic and surgical problems in the management of primary aldosteronism

13 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

PRIMARY ALDOSTERONISM DUE TO AN ADRENAL CARCINOMA

13 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Pathology of primary aldosteronism

13 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Hypermineralocorticoidism.

13 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Primary adrenocortical carcinoma causing aldosteronism

13 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Carcinoma of the Adrenal Cortex with Hyperaldosteronism

13 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Primary Aldosteronism Due to a Malignant Ovarian Tumor

13 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Low-renin ("primary") hyperaldosteronism. Differential diagnosis and distinction of sub-groups within the syndrome

13 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone

13 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.

13 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration

13 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess

13 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes

13 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Response of plasma aldosterone to fludrocortisone in primary hyperaldosteronism and other forms of hypertension

13 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The treatment of low-renin ("primary") hyperaldosteronism

13 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

An International Collaborative Study of Renin Assay: Establishment of the International Reference Preparation of Human Renin

13 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Falsely High Plasma Potassium Values in Patients with Hyperaldosteronism

13 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The estimation of renin in human plasma

13 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Measurement of plasma renin-substrate in man

13 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.

13 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Double isotope assay of aldosterone, corticosterone and cortisol in human peripheral plasma.

13 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Estimation of aldosterone, 11-deoxycorticosterone, 18-hydroxy-11-deoxy-corticosterone, corticosterone, cortisol and 11-deoxycortisol in human plasma by gas-liquid chromatography with electron capture detection

13 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The measurement of exchangeable sodium in man using the isotope 24Na

13 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The measurement of exchangeable potassium in man by isotope dilution

13 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Simultaneous measurement of total exchangeable potassium and sodium using 43K and 24Na

13 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Estimation of extracellular fluid volume using radiobromine

13 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin.

13 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism

13 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?

13 August 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Renal abnormality of essential hypertension.

13 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Essential hypertension: renin and aldosterone, heart attack and stroke.

13 August 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Renin levels in hypertension

13 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

New thoughts on essential hypertension.

13 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Plasma Renin Levels and Vascular Complications in Hypertension

13 August 2023

79

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Are patients with essential hypertension and low renin protected against stroke and heart attack?

13 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

13 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

PRIMARY ALDOSTERONISM WITH MALIGNANT HYPERTENSION

13 August 2023

84

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Association of Accelerated (Malignant) Hypertension in a Patient with Primary Aldosteronism

13 August 2023

85

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Malignant hypertension with aldosteronoma producing adenoma

13 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Malignant Hypertension in a Patient with Conn's Syndrome

13 August 2023

88

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Tertiary Hyperparathyroidism

13 August 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Parathyroid adenomas in chronic rickets

13 August 2023

92

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The meaning of aldosteronism in hypertensive disease

13 August 2023

97

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism

13 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria

13 August 2023

99

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Hyporeninemic hypertension

13 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The prevalence of hypertension in an unselected population, and the frequency of abnormalities of potassium, angiotensin II and aldosterone in hypertensive subjects

13 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

In vivo and in vitro studies of adrenal secretions in Cushing's syndrome and primary aldosteronism

13 August 2023

105

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

The Steroid Content of Adrenal Adenomas and Measurements of Aldosterone Production in Patients with Essential Hypertension and Primary Aldosteronism*

13 August 2023

106

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Desoxycorticosterone secretion rates in hyperadrenocorticism

13 August 2023

107

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Comparison of the effect of aldosterone and cortexone (desoxycorticosterone) on electrolyte excretion in man

13 August 2023

108

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Adrenocortical nodular hyperplasia: the ageing adrenal

13 August 2023

111

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Functional and morphological observations on rat adrenal zona glomerulosa cells in monolayer culture

13 August 2023

112

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

Studies on the biosynthesis of aldosterone in solitary adenoma and in nodular hyperplasia of the adrenal cortex in patients exhibiting Conn's syndrome

13 August 2023

115

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

[Hypokalemic and normokalemic primary aldosteronism. A contribution to the differential diagnosis of essential hypertonia]

13 August 2023

116

1 reference

https://api.crossref.org/works/10.1016/0002-8703(78)90370-8

13 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:622981 AND SRC:MED&resulttype=core&format=json

11 September 2019

1 reference